Drugs / HRS-7172
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07142980 | Sep 2025 → Dec 2028 expected | — | Jiangsu HengRui Medicine Co., Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HRS-7172 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07142980 ↗ |
| Route | Oral | “Oral HRS-7172.” NCT07142980 ↗ |